Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 77Observational 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Prostatic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myasthenia Gravis 3Neoplasm Metastasis 2Lymphoma, Follicular 2Lymphoma 2Recurrence 1Neoplasm, Residual 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Rituximab 6Polymerase Chain Reaction 6Amplified Fragment Length Polymorphism Analysis 6Gene Expression Profiling 5obinutuzumab 4Surveys and Questionnaires 4Psychiatric Rehabilitation 4Microarray Analysis 4Immunohistochemistry 4Flow Cytometry 4Therapeutics 3Immunoenzyme Techniques 3Drug Therapy 3tisagenlecleucel 2duvelisib 2Prednisone 2Lenalidomide 2Influenza Vaccines 2Immunologic Techniques 2Echocardiography 2Blood Specimen Collection 2zanubrutinib 1tazemetostat 1relmacabtagene autoleucel 1pomalidomide 1ibritumomab tiuxetan 1deucravacitinib 1Watchful Waiting 1Waiting Lists 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Lymphoma, Follicular × Prednisone × Clear all
NCT07609446 2026-05-27

Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma

The First Affiliated Hospital of Soochow University

Not yet recruiting
30 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT05899621 2023-06-12

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

Ruijin Hospital

Recruiting
332 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡